XML 33 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements Of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Balance at the beginning of the period (in shares) at Dec. 31, 2021   43,676      
Balance at the beginning of the period at Dec. 31, 2021 $ 267,091 $ 0 $ 528,666 $ (54) $ (261,521)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   401      
Issuance of common stock under stock plans 1,291   1,291    
Stock-based compensation expense 1,552   1,552    
Unrealized gain (loss) on cash equivalents 1     1  
Net loss (17,185)       (17,185)
Balance at the end of the period (in shares) at Mar. 31, 2022   44,077      
Balance at the end of the period at Mar. 31, 2022 252,750 $ 0 531,509 (53) (278,706)
Balance at the beginning of the period (in shares) at Dec. 31, 2021   43,676      
Balance at the beginning of the period at Dec. 31, 2021 267,091 $ 0 528,666 (54) (261,521)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (58,982)        
Balance at the end of the period (in shares) at Sep. 30, 2022   44,714      
Balance at the end of the period at Sep. 30, 2022 220,762 $ 0 541,048 217 (320,503)
Balance at the beginning of the period (in shares) at Mar. 31, 2022   44,077      
Balance at the beginning of the period at Mar. 31, 2022 252,750 $ 0 531,509 (53) (278,706)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   461      
Issuance of common stock under stock plans 2,861   2,861    
Stock-based compensation expense 2,676   2,676    
Unrealized gain (loss) on cash equivalents 85     85  
Net loss (19,184)       (19,184)
Balance at the end of the period (in shares) at Jun. 30, 2022   44,538      
Balance at the end of the period at Jun. 30, 2022 239,188 $ 0 537,046 32 (297,890)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   176      
Issuance of common stock under stock plans 777   777    
Stock-based compensation expense 3,225   3,225    
Unrealized gain (loss) on cash equivalents 185     185  
Net loss (22,613)       (22,613)
Balance at the end of the period (in shares) at Sep. 30, 2022   44,714      
Balance at the end of the period at Sep. 30, 2022 $ 220,762 $ 0 541,048 217 (320,503)
Balance at the beginning of the period (in shares) at Dec. 31, 2022 44,828 44,828      
Balance at the beginning of the period at Dec. 31, 2022 $ 197,072 $ 0 545,753 (6) (348,675)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   181      
Issuance of common stock under stock plans 380   380    
Stock-based compensation expense 4,137   4,137    
Unrealized gain (loss) on cash equivalents 21     21  
Net loss (28,484)       (28,484)
Balance at the end of the period (in shares) at Mar. 31, 2023   45,009      
Balance at the end of the period at Mar. 31, 2023 $ 173,126 $ 0 550,270 15 (377,159)
Balance at the beginning of the period (in shares) at Dec. 31, 2022 44,828 44,828      
Balance at the beginning of the period at Dec. 31, 2022 $ 197,072 $ 0 545,753 (6) (348,675)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (78,393)        
Balance at the end of the period (in shares) at Sep. 30, 2023 50,473 50,473      
Balance at the end of the period at Sep. 30, 2023 $ 299,356 $ 0 726,428 (6) (427,066)
Balance at the beginning of the period (in shares) at Mar. 31, 2023   45,009      
Balance at the beginning of the period at Mar. 31, 2023 173,126 $ 0 550,270 15 (377,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   262      
Issuance of common stock under stock plans 2,430   2,430    
Stock-based compensation expense 5,652   5,652    
Unrealized gain (loss) on cash equivalents (21)     (21)  
Net loss (25,285)       (25,285)
Balance at the end of the period (in shares) at Jun. 30, 2023   45,271      
Balance at the end of the period at Jun. 30, 2023 155,902 $ 0 558,352 (6) (402,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   117      
Issuance of common stock under stock plans 414   414    
Stock issuance costs 10,795        
Issuance of common stock, net of issuance costs (in shares)   5,085      
Issuance of common stock, net of issuance costs of $10,795 161,705   161,705    
Stock-based compensation expense 5,957   5,957    
Net loss $ (24,622)       (24,622)
Balance at the end of the period (in shares) at Sep. 30, 2023 50,473 50,473      
Balance at the end of the period at Sep. 30, 2023 $ 299,356 $ 0 $ 726,428 $ (6) $ (427,066)